Clinical Trial Update: Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether adding radiation to HER2-targeted therapy improves outcomes versus HER2-targeted therapy alone in low-risk HER2-positive brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: NRG Oncology | Conditions: HER2-positive Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING